These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31734380)

  • 1. Early antibody responses map to non-protective, PCV2 capsid protein epitopes.
    Ilha M; Nara P; Ramamoorthy S
    Virology; 2020 Jan; 540():23-29. PubMed ID: 31734380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of one critical amino acid that determines a conformational neutralizing epitope in the capsid protein of porcine circovirus type 2.
    Huang LP; Lu YH; Wei YW; Guo LJ; Liu CM
    BMC Microbiol; 2011 Aug; 11():188. PubMed ID: 21859462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs.
    Matzinger SR; Opriessnig T; Xiao CT; Catanzaro N; Beach NM; Slade DE; Nitzel GP; Meng XJ
    Virology; 2016 Nov; 498():82-93. PubMed ID: 27564544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of phage display to identify antigenic regions in the PCV2 capsid protein for the evaluation of serological responses in mice and pigs.
    Santos MR; Assao VS; Santos FAA; Salgado RL; Carneiro AP; Fietto JLR; Bressan GC; de Almeida MR; Lobato ZIP; Ueira-Veira C; Goulart LR; Silva-Júnior A
    Arch Virol; 2018 Jul; 163(7):1877-1887. PubMed ID: 29589172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization Mechanism of a Monoclonal Antibody Targeting a Porcine Circovirus Type 2 Cap Protein Conformational Epitope.
    Huang L; Sun Z; Xia D; Wei Y; Sun E; Liu C; Zhu H; Bian H; Wu H; Feng L; Wang J; Liu C
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacing the decoy epitope of PCV2 capsid protein with epitopes of GP3 and/or GP5 of PRRSV enhances the immunogenicity of bivalent vaccines in mice.
    Jung BK; Kim HR; Jang H; Chang KS
    J Virol Methods; 2020 Oct; 284():113928. PubMed ID: 32650038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody recognition of porcine circovirus type 2 capsid protein epitopes after vaccination, infection, and disease.
    Trible BR; Kerrigan M; Crossland N; Potter M; Faaberg K; Hesse R; Rowland RR
    Clin Vaccine Immunol; 2011 May; 18(5):749-57. PubMed ID: 21430122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine mapping of antigenic epitopes on capsid proteins of porcine circovirus, and antigenic phenotype of porcine circovirus type 2.
    Shang SB; Jin YL; Jiang XT; Zhou JY; Zhang X; Xing G; He JL; Yan Y
    Mol Immunol; 2009 Jan; 46(3):327-34. PubMed ID: 19059648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxyl-Terminal Decoy Epitopes in the Capsid Protein of Porcine Circovirus Type 2 Are Immunogenicity-Enhancers That Elicit Predominantly Specific Antibodies in Non-Vaccinated Pigs.
    Hung LC
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice.
    Guo XQ; Wang LQ; Qiao H; Yang XW; Yang MF; Chen HY
    Microbiol Immunol; 2015 Mar; 59(3):174-80. PubMed ID: 25664504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell epitope content comparison (EpiCC) analysis demonstrates a bivalent PCV2 vaccine has greater T cell epitope overlap with field strains than monovalent PCV2 vaccines.
    Bandrick M; Gutiérrez AH; Desai P; Rincon G; Martin WD; Terry FE; De Groot AS; Foss DL
    Vet Immunol Immunopathol; 2020 May; 223():110034. PubMed ID: 32278900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of neutralizing and non-neutralizing antibody responses against Porcine circovirus 2 in vaccinated and non-vaccinated farmed pigs.
    Solis Worsfold C; Dardari R; Law S; Eschbaumer M; Nourozieh N; Marshall F; Czub M
    J Gen Virol; 2015 Sep; 96(9):2743-2748. PubMed ID: 26033118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ORF2 protein-based ELISA for porcine circovirus type 2 antibodies in post-weaning multisystemic wasting syndrome.
    Blanchard P; Mahé D; Cariolet R; Truong C; Le Dimna M; Arnauld C; Rose N; Eveno E; Albina E; Madec F; Jestin A
    Vet Microbiol; 2003 Jul; 94(3):183-94. PubMed ID: 12814886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A commercial PCV2a-based vaccine is effective in protection from experimental challenge of PCV2 mutant with two amino acids elongation in capsid protein.
    Guo LJ; Fu YJ; Huang LP; Wang YP; Wei YW; Wu HL; Liu CM
    Vaccine; 2015 Jul; 33(31):3752-7. PubMed ID: 26051516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.
    Fenaux M; Opriessnig T; Halbur PG; Elvinger F; Meng XJ
    J Virol; 2004 Jun; 78(12):6297-303. PubMed ID: 15163723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope screening of the PCV2 Cap protein by use of a random peptide-displayed library and polyclonal antibody.
    Ge M; Yan A; Luo W; Hu YF; Li RC; Jiang DL; Yu XL
    Virus Res; 2013 Oct; 177(1):103-7. PubMed ID: 23845304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and immunogenicity of a recombinant pseudorabies virus expressing cap protein of porcine circovirus type 2.
    Song Y; Jin M; Zhang S; Xu X; Xiao S; Cao S; Chen H
    Vet Microbiol; 2007 Jan; 119(2-4):97-104. PubMed ID: 17005335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of porcine circovirus type 2 capsid protein targeting to different subcellular compartments.
    Fan H; Xiao S; Tong T; Wang S; Xie L; Jiang Y; Chen H; Fang L
    Mol Immunol; 2008 Feb; 45(3):653-60. PubMed ID: 17709139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
    Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
    Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of a decoy epitope in porcine circovirus 2 (PCV2) capsid protein affects the protective immune response in mice.
    Kim K; Shin M; Hahn TW
    Arch Virol; 2020 Dec; 165(12):2829-2835. PubMed ID: 33000310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.